Skip to main content
Marc Barry, MD
Subspecialty Director: Genitourinary Pathology
Subspecialties: Genitourinary and medical renal pathology
Associate Professor, University of Utah School of Medicine Specialties Renal pathology Genitourinary Education Medical Degree—University College Dublin Residency—Anatomic Pathology, Brigham and Women’s Hospital Research Fellowship—Massachusetts Institute of Technology Fellowship—Medical Renal Pathology, Brigham and Women’s Hospital Fellowship—Urologic Pathology, Brigham and Women’s Hospital Certifications/Affiliations American Board of Pathology United States and Canadian Academy of Pathology American Society for Clinical Pathology College of American Pathologists Research Interests Clinicopathologic questions in medical renal and urologic pathology Epidemiologic and translational aspects of urologic neoplasia Awards Registrar’s Prize for Research from the Royal Academy of Medicine in Ireland, 2000 Research Scholarship Award from the College of American Pathology Foundation, 2004 Prize from the journal “Urology” for the best paper in 2007 by a resident or fellow, 2008 Formally recognized for “Excellence in Urologic Resident Education” by the Division of Urology, University of New Mexico School of Medicine, 2014 Recent Publications Berggren KL, Restrepo Cruz S, Hixon MD, et al. MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma . Oncogene . 2019;38(48):7329-7341. Nash SH, Meisner ALW, Zimpelman GL, et al. Cancer survival among Alaska Native people . Cancer . 2018;124(12):2570-2577. Hill DA, Friend S, Lomo L, et al. Breast cancer survival, survival disparities, and guideline-based treatment . Breast Cancer Res Treat . 2018;170(2):405-414. Hill DA, Barry M, Wiggins C, et al. Estrogen receptor quantitative measures and breast cancer survival . Breast Cancer Res Treat . 2017;166(3): 855-864. Teixeira AA, Marchiò S, Dias-Neto E, et al. Going viral? Linking the etiology of human prostate cancer to the PCA3 long noncoding RNA and oncogenic viruses . EMBO Mol Med . 2017;9(10):1327-1330.